JPRN-UMIN000011350Completed未知
Efficaty and safety of corneal collagen cross-linking for keratoconus, keratectasia and infectious keratitis - Efficacy and safety of CXL for keratoconus and other diseases.
Tokyo Dental College Ichikawa General Hospital0 sites15 target enrollmentStarted: August 2, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 14years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Corneal thickness less than 400 micrometers Unknown infectious keratitis Other ocular diseases
Investigators
Similar Trials
Not yet recruiting
Not Applicable
ong term efficacy of cornea collagen cross-linking (CXL) in Pellucid Marginal Degeneration (PMD)H18.711-71PMD, Pellucid Marginal Degeneration.Pellucid Marginal DegenerationIRCT20130306012724N4Esfahan University of Medical Sciences40
Completed
Not Applicable
Efficacy and safety of corneal crosslinking using KXL for keratoconic eyesKeratoconusJPRN-UMIN000014719Department of Ophthalmology, Ichikawa General Hospital, Tokyo Dental College10
Completed
Not Applicable
sefulness of Corneal Cross-linkingJPRN-UMIN000006530kitasato university department of ophthalmology20
Terminated
Not Applicable
Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)Bacterial KeratitisFungal KeratitisNCT02088970Nantes University Hospital21
Completed
Not Applicable
Effectiveness of customized corneal crosslinking versus standard corneal crosslinking in patients with progressive keratoconusabnormal cone-shaped protrusion of the corneaconical cornea10002693NL-OMON52376Medisch Universitair Ziekenhuis Maastricht124